nitrites has been researched along with Hypercholesterolemia in 34 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We examined whether hypercholesterolemia inhibits vasculogenic effects of transplanted human circulating progenitor cells in ischemic tissue and whether L-arginine, a nitric oxide donor, might prevent impairment." | 7.76 | Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia-induced endothelial dysfunction and rescue with L-arginine supplementation. ( Chan, V; Hazra, S; Kumarathasan, P; Mesana, TG; Price, J; Ruel, M; Sellke, FW; Suuronen, EJ; Veinot, JP; Vincent, R; Zhang, P; Zhang, Y, 2010) |
| "Ezetimibe ameliorated the status of metabolic syndrome and microalbuminuria, reduced inflammation and oxidative stress, and increased nitric oxide bioavailability in a LDL-chol reduction-dependent and -independent manner." | 7.76 | Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia. ( Aihara, K; Akaike, M; Dagvasumberel, M; Hirata, Y; Ishikawa, K; Iwase, T; Koshiba, K; Kusunose, K; Matsumoto, T; Niki, T; Sata, M; Soeki, T; Sumitomo-Ueda, Y; Taketani, Y; Tomita, N; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K; Yoshida, S, 2010) |
| " The present study is aimed to investigate the effect of L-arginine (as a natural NO donor) supplementation on NO metabolite in a rabbit model of hypercholesterolemia to find a reliable marker for endothelial NO production." | 7.74 | L-arginine supplementation influenced nitrite but not nitrate and total nitrite in rabbit model of hypercholesterolemia. ( Haghjooy Javanmard, S; Monajemi, A; Nematbakhsh, M, 2008) |
| "In this study, plasma NO2- and NO3- (NOx-) levels were studied after lowering cholesterol with simvastatin in 26 outpatients with hypercholesterolemia (male, 9; female, 17; mean age, 59 +/- 12 years; cholesterol level > 220 mg/dl)." | 7.69 | Simvastatin increases plasma NO2- and NO3- levels in patients with hypercholesterolemia. ( Kuroiwa, A; Nakashima, Y; Tanaka, S; Tasaki, H; Toyokawa, Y; Yamashita, K; Yashiro, A, 1996) |
| "Hypercholesterolemia is a major risk factor for the development and progression of cardiovascular diseases including atherosclerosis." | 5.35 | Suppression of diet-induced hypercholesterolemia by scutellarin in rats. ( Chan, SW; Chen, SL; Cheng, HL; Guo, DJ; Li, Q; Wu, JH, 2009) |
| "We discovered that in the patients with chronic coronary heart disease (CHD) the mean value of nitrites was 18 +/- 0." | 4.79 | Nitrite plasma levels in acute and chronic coronary heart disease. ( Ferlito, S; Gallina, M, 1997) |
| " We examined whether hypercholesterolemia inhibits vasculogenic effects of transplanted human circulating progenitor cells in ischemic tissue and whether L-arginine, a nitric oxide donor, might prevent impairment." | 3.76 | Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia-induced endothelial dysfunction and rescue with L-arginine supplementation. ( Chan, V; Hazra, S; Kumarathasan, P; Mesana, TG; Price, J; Ruel, M; Sellke, FW; Suuronen, EJ; Veinot, JP; Vincent, R; Zhang, P; Zhang, Y, 2010) |
| "Ezetimibe ameliorated the status of metabolic syndrome and microalbuminuria, reduced inflammation and oxidative stress, and increased nitric oxide bioavailability in a LDL-chol reduction-dependent and -independent manner." | 3.76 | Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia. ( Aihara, K; Akaike, M; Dagvasumberel, M; Hirata, Y; Ishikawa, K; Iwase, T; Koshiba, K; Kusunose, K; Matsumoto, T; Niki, T; Sata, M; Soeki, T; Sumitomo-Ueda, Y; Taketani, Y; Tomita, N; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K; Yoshida, S, 2010) |
| "The impact of L-arginine on atherogenesis and its ability to prevent endothelial dysfunction have been studied extensively during the past years." | 3.74 | The prevention of endothelial dysfunction through endothelial cell apoptosis inhibition in a hypercholesterolemic rabbit model: the effect of L-arginine supplementation. ( Haghjooyjavanmard, S; Mahmoodi, F; Monajemi, AR; Nematbakhsh, M, 2008) |
| " The present study is aimed to investigate the effect of L-arginine (as a natural NO donor) supplementation on NO metabolite in a rabbit model of hypercholesterolemia to find a reliable marker for endothelial NO production." | 3.74 | L-arginine supplementation influenced nitrite but not nitrate and total nitrite in rabbit model of hypercholesterolemia. ( Haghjooy Javanmard, S; Monajemi, A; Nematbakhsh, M, 2008) |
| " Forearm blood flow (FBF) during reactive hyperemia and after sublingual nitroglycerin (NTG) administration was measured by strain-gauge plethysmography." | 3.71 | Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women. ( Chayama, K; Higashi, Y; Kimura, M; Kodama, I; Nakagawa, K; Ohama, K; Sanada, M; Tsuda, M, 2002) |
| " We examined the hypothesis that HC may inhibit ischemia-induced angiogenesis by inhibition of EDNO in a rat model of unilateral hindlimb ischemia and that oral L-arginine supplementation, a substrate for NO synthase, may prevent HC-related impairment of angiogenesis." | 3.70 | Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. ( Duan, J; Ikeda, H; Imaizumi, T; Katoh, A; Kawata, H; Murohara, T; Sasaki, K; Shintani, S; Yamamoto, N, 2000) |
| "In this study, plasma NO2- and NO3- (NOx-) levels were studied after lowering cholesterol with simvastatin in 26 outpatients with hypercholesterolemia (male, 9; female, 17; mean age, 59 +/- 12 years; cholesterol level > 220 mg/dl)." | 3.69 | Simvastatin increases plasma NO2- and NO3- levels in patients with hypercholesterolemia. ( Kuroiwa, A; Nakashima, Y; Tanaka, S; Tasaki, H; Toyokawa, Y; Yamashita, K; Yashiro, A, 1996) |
| "Hypercholesterolemia is linked to endothelial dysfunction and enhancement of the endogenous inhibitor of NO synthase." | 2.71 | Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects. ( Abdalla, DS; Bersch, D; Bertolami, MC; Faludi, AA; Pereira, EC; Salem, M, 2003) |
| "Hypertension was induced by L-N(G)-nitroarginine methyl ester (L-NAME) and hypercholesterolemia was induced by feeding rats with a diet containing 1% cholesterol." | 1.46 | Protective effect of the standardized extract of ginkgo biloba (EGb761) against hypertension with hypercholesterolemia-induced renal injury in rats: Insights in the underlying mechanisms. ( Abd-Eldayem, AM; Abdel-Zaher, AO; El-Refaiy, AEM; Farghaly, HSM, 2017) |
| "Hypercholesterolemia is associated with decreased nitric oxide (NO) bioavailability and endothelial dysfunction, a phenomenon thought to have a major role in the altered cerebral blood flow evident in stroke." | 1.36 | Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice. ( Ahluwalia, A; Duchene, J; Hattori, N; Milsom, AB; Panayiotou, C; Urabe, T; Yamashiro, K, 2010) |
| "Hypercholesterolemia is a major risk factor for the development and progression of cardiovascular diseases including atherosclerosis." | 1.35 | Suppression of diet-induced hypercholesterolemia by scutellarin in rats. ( Chan, SW; Chen, SL; Cheng, HL; Guo, DJ; Li, Q; Wu, JH, 2009) |
| "Atherosclerosis is enhanced in arterial segments exposed to disturbed flow." | 1.35 | Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis. ( Balestrieri, ML; Crimi, E; D'Armiento, FP; De Rosa, G; Lerman, LO; Napoli, C; Schiano, C; Servillo, L; Sica, V, 2008) |
| "Treatment with rosiglitazone enhanced PPARgamma expression, improved endothelium-dependent vasodilatation, preserved P-VASP, suppressed gp91phox and iNOS expression, reduced superoxide and total NOx production, and inhibited nitrotyrosine formation." | 1.32 | Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. ( Batinic-Haberle, I; Christopher, TA; Gao, E; Liu, HR; Lopez, BL; Ma, XL; Ohlstein, EH; Tao, L; Teng, ZP; Willette, RN; Yue, TL, 2003) |
| "In patients with >50% stenosis, NO(2)(-)/HDL-C was only shown to change significantly in relation to obstructive artery number (p=0." | 1.32 | Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis. ( Afrasyap, L; Oztürk, G, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (23.53) | 18.2507 |
| 2000's | 16 (47.06) | 29.6817 |
| 2010's | 9 (26.47) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Namwong, A | 1 |
| Kumphune, S | 1 |
| Seenak, P | 1 |
| Chotima, R | 1 |
| Nernpermpisooth, N | 1 |
| Malakul, W | 1 |
| Abdel-Zaher, AO | 1 |
| Farghaly, HSM | 1 |
| El-Refaiy, AEM | 1 |
| Abd-Eldayem, AM | 1 |
| Andrade, VL | 1 |
| Sertório, JT | 1 |
| Eleuterio, NM | 1 |
| Tanus-Santos, JE | 1 |
| Fernandes, KS | 1 |
| Sandrim, VC | 1 |
| Velmurugan, S | 1 |
| Gan, JM | 1 |
| Rathod, KS | 1 |
| Khambata, RS | 1 |
| Ghosh, SM | 1 |
| Hartley, A | 1 |
| Van Eijl, S | 1 |
| Sagi-Kiss, V | 1 |
| Chowdhury, TA | 1 |
| Curtis, M | 1 |
| Kuhnle, GG | 1 |
| Wade, WG | 1 |
| Ahluwalia, A | 2 |
| Nematbakhsh, M | 2 |
| Haghjooyjavanmard, S | 1 |
| Mahmoodi, F | 1 |
| Monajemi, AR | 1 |
| Haghjooy Javanmard, S | 1 |
| Monajemi, A | 1 |
| Lundberg, JO | 1 |
| Li, Q | 1 |
| Wu, JH | 1 |
| Guo, DJ | 1 |
| Cheng, HL | 1 |
| Chen, SL | 1 |
| Chan, SW | 1 |
| Iliodromitis, EK | 1 |
| Andreadou, I | 1 |
| Prokovas, E | 1 |
| Zoga, A | 1 |
| Farmakis, D | 1 |
| Fotopoulou, T | 1 |
| Ioannidis, K | 1 |
| Paraskevaidis, IA | 1 |
| Kremastinos, DT | 1 |
| Suuronen, EJ | 1 |
| Hazra, S | 1 |
| Zhang, P | 1 |
| Vincent, R | 1 |
| Kumarathasan, P | 1 |
| Zhang, Y | 1 |
| Price, J | 1 |
| Chan, V | 1 |
| Sellke, FW | 1 |
| Mesana, TG | 1 |
| Veinot, JP | 1 |
| Ruel, M | 1 |
| Yagi, S | 1 |
| Akaike, M | 1 |
| Aihara, K | 1 |
| Iwase, T | 1 |
| Ishikawa, K | 1 |
| Yoshida, S | 1 |
| Sumitomo-Ueda, Y | 1 |
| Kusunose, K | 1 |
| Niki, T | 1 |
| Yamaguchi, K | 1 |
| Koshiba, K | 1 |
| Hirata, Y | 2 |
| Dagvasumberel, M | 1 |
| Taketani, Y | 1 |
| Tomita, N | 1 |
| Yamada, H | 1 |
| Soeki, T | 1 |
| Wakatsuki, T | 1 |
| Matsumoto, T | 1 |
| Sata, M | 1 |
| Yamashiro, K | 1 |
| Milsom, AB | 1 |
| Duchene, J | 1 |
| Panayiotou, C | 1 |
| Urabe, T | 1 |
| Hattori, N | 1 |
| Ozsoy, O | 2 |
| Hacioglu, G | 2 |
| Savcioglu, F | 2 |
| Kucukatay, V | 2 |
| Yargicoglu, P | 2 |
| Agar, A | 2 |
| Sanada, M | 1 |
| Higashi, Y | 1 |
| Nakagawa, K | 1 |
| Tsuda, M | 1 |
| Kodama, I | 1 |
| Kimura, M | 1 |
| Chayama, K | 1 |
| Ohama, K | 1 |
| Pereira, EC | 1 |
| Bertolami, MC | 2 |
| Faludi, AA | 1 |
| Salem, M | 1 |
| Bersch, D | 1 |
| Abdalla, DS | 2 |
| Tao, L | 1 |
| Liu, HR | 1 |
| Gao, E | 1 |
| Teng, ZP | 1 |
| Lopez, BL | 1 |
| Christopher, TA | 1 |
| Ma, XL | 1 |
| Batinic-Haberle, I | 1 |
| Willette, RN | 1 |
| Ohlstein, EH | 1 |
| Yue, TL | 1 |
| Afrasyap, L | 1 |
| Oztürk, G | 1 |
| Rajamannan, NM | 1 |
| Subramaniam, M | 1 |
| Stock, SR | 1 |
| Stone, NJ | 1 |
| Springett, M | 1 |
| Ignatiev, KI | 1 |
| McConnell, JP | 1 |
| Singh, RJ | 1 |
| Bonow, RO | 1 |
| Spelsberg, TC | 1 |
| Taniguchi, J | 1 |
| Honda, H | 1 |
| Shibusawa, Y | 1 |
| Iwata, T | 1 |
| Notoya, Y | 1 |
| Kremins'ka, IB | 1 |
| Levyts'kyĭ, VA | 1 |
| Napoli, C | 1 |
| Balestrieri, ML | 1 |
| Sica, V | 1 |
| Lerman, LO | 1 |
| Crimi, E | 1 |
| De Rosa, G | 1 |
| Schiano, C | 1 |
| Servillo, L | 1 |
| D'Armiento, FP | 1 |
| Nakashima, Y | 2 |
| Toyokawa, Y | 1 |
| Tanaka, S | 2 |
| Yamashita, K | 1 |
| Yashiro, A | 2 |
| Tasaki, H | 1 |
| Kuroiwa, A | 2 |
| Nanri, H | 1 |
| Ikeda, M | 1 |
| Ferlito, S | 3 |
| Gallina, M | 3 |
| Kang, BP | 1 |
| Mehta, U | 1 |
| Bansal, MP | 1 |
| Minami, M | 1 |
| Atarashi, K | 1 |
| Ishiyama, A | 1 |
| Goto, A | 1 |
| Omata, M | 1 |
| Kano, H | 2 |
| Hayashi, T | 2 |
| Sumi, D | 2 |
| Esaki, T | 1 |
| Asai, Y | 1 |
| Thakur, NK | 2 |
| Jayachandran, M | 1 |
| Iguchi, A | 2 |
| Catassi, S | 2 |
| Bisicchia, A | 2 |
| Di Salvo, M | 1 |
| Di Salvo, MM | 1 |
| Duan, J | 1 |
| Murohara, T | 1 |
| Ikeda, H | 1 |
| Katoh, A | 1 |
| Shintani, S | 1 |
| Sasaki, K | 1 |
| Kawata, H | 1 |
| Yamamoto, N | 1 |
| Imaizumi, T | 1 |
| Rahman, MM | 1 |
| Varghese, Z | 1 |
| Moorhead, JF | 1 |
| Moriel, P | 1 |
| Pereira, IR | 1 |
| Tsunekawa, T | 1 |
| Matsui-Hirai, H | 1 |
| Egashira, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-blind, Randomised, Placebo-controlled Parallel Study to Investigate the Influence of Dietary Nitrate on Skin Inflammation in Healthy Volunteers[NCT03183830] | Phase 1 | 24 participants (Actual) | Interventional | 2017-02-02 | Completed | ||
| Investigation of Dietary Nitrate Optimisation by Hyperuricaemia Stratification in Heart Failure[NCT03511248] | Phase 2 | 92 participants (Anticipated) | Interventional | 2018-06-01 | Active, not recruiting | ||
| Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function, Platelet Reactivity in Hypercholesterolemics Without Known Cardiovascular Disease or Atherosclerosis.[NCT01493752] | Phase 1 | 69 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| Rosuvastatin Affecting Aortic Valve Endothelium - RAAVE[NCT00114491] | 200 participants | Observational | 2003-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nitrites and Hypercholesterolemia
| Article | Year |
|---|---|
Nitrite plasma levels in acute and chronic coronary heart disease.
Topics: Acute Disease; Aged; Chronic Disease; Coronary Disease; Female; Humans; Hypercholesterolemia; Hypert | 1997 |
3 trials available for nitrites and Hypercholesterolemia
| Article | Year |
|---|---|
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Atherosclerosis; Bacteria; Beta vulgaris; Blood Platelets; Diet; Double-Blind Method; Female; | 2016 |
Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.
Topics: Anticholesteremic Agents; Arginine; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; | 2003 |
Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days.
Topics: Aged; Brachial Artery; Cyclic GMP; Diabetes Complications; Diabetes Mellitus; Endothelium, Vascular; | 2001 |
30 other studies available for nitrites and Hypercholesterolemia
| Article | Year |
|---|---|
Pineapple fruit improves vascular endothelial dysfunction, hepatic steatosis, and cholesterol metabolism in rats fed a high-cholesterol diet.
Topics: Ananas; Animals; Antioxidants; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Diet; Fatty Liver; Frui | 2022 |
Protective effect of the standardized extract of ginkgo biloba (EGb761) against hypertension with hypercholesterolemia-induced renal injury in rats: Insights in the underlying mechanisms.
Topics: Animals; Blood Pressure; Creatinine; Diastole; Ginkgo biloba; Glutathione; Hypercholesterolemia; Hyp | 2017 |
Simvastatin treatment increases nitrite levels in obese women: modulation by T(-786)C polymorphism of eNOS.
Topics: Anticholesteremic Agents; Female; Humans; Hypercholesterolemia; Nitric Oxide Synthase Type III; Nitr | 2013 |
The prevention of endothelial dysfunction through endothelial cell apoptosis inhibition in a hypercholesterolemic rabbit model: the effect of L-arginine supplementation.
Topics: Animals; Aorta; Apoptosis; Arginine; Atherosclerosis; Cell Count; Cholesterol; Dietary Supplements; | 2008 |
L-arginine supplementation influenced nitrite but not nitrate and total nitrite in rabbit model of hypercholesterolemia.
Topics: Animals; Arginine; Cholesterol; Dietary Supplements; Disease Models, Animal; Hypercholesterolemia; M | 2008 |
Cardiovascular prevention by dietary nitrate and nitrite.
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Diet; Endothelium, Vascular; Humans; Hyp | 2009 |
Suppression of diet-induced hypercholesterolemia by scutellarin in rats.
Topics: Animals; Anticholesteremic Agents; Apigenin; Cholesterol; Disease Models, Animal; Drugs, Chinese Her | 2009 |
Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation.
Topics: Animals; Anticholesteremic Agents; Biomarkers; Cholesterol, LDL; Hemodynamics; Hypercholesterolemia; | 2010 |
Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia-induced endothelial dysfunction and rescue with L-arginine supplementation.
Topics: Animals; Arginine; Cytokines; Endothelial Cells; Endothelin-1; Extremities; Humans; Hypercholesterol | 2010 |
Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Anticholesteremic Agents; Azetidines; C-Reactive Pro | 2010 |
Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice.
Topics: Animals; Aorta; Apolipoproteins E; Cells, Cultured; Cilostazol; Cyclic GMP; Endothelin-1; Endotheliu | 2010 |
The effect of sodium metabisulphite on active avoidance performance in hypercholesterolemic rats.
Topics: Animals; Antioxidants; Avoidance Learning; Cholesterol; Hippocampus; Hypercholesterolemia; Male; Nit | 2012 |
The effect of sodium metabisulfite on visual evoked potentials in rats with hypercholesterolemia.
Topics: Animals; Antioxidants; Brain; Cholesterol; Cholesterol, Dietary; Evoked Potentials, Visual; Hypercho | 2011 |
Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
Topics: Arteries; Blood Flow Velocity; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Estradiol; | 2002 |
Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.
Topics: Animals; Antioxidants; Blood Vessels; Carotid Arteries; Cyclic GMP; Cyclic GMP-Dependent Protein Kin | 2003 |
Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis.
Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary A | 2004 |
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve.
Topics: Animals; Anticholesteremic Agents; Aortic Valve; Atorvastatin; Blotting, Western; C-Reactive Protein | 2005 |
Alteration in endothelial function and modulation by treatment with pioglitazone in rabbit renal artery from short-term hypercholesterolemia.
Topics: Acetylcholine; Animals; Biological Factors; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhib | 2005 |
[Effect of the physical loadings of different intensity on atherogenesis in rats].
Topics: Animals; Atherosclerosis; Femoral Artery; Hypercholesterolemia; Male; Nitrites; Physical Exertion; R | 2007 |
Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis.
Topics: Administration, Oral; Animals; Antioxidants; Atherosclerosis; Cells, Cultured; Disease Models, Anima | 2008 |
Simvastatin increases plasma NO2- and NO3- levels in patients with hypercholesterolemia.
Topics: Administration, Oral; Anticholesteremic Agents; Cholesterol, LDL; Cholesterol, VLDL; Female; Follow- | 1996 |
Plasma nitrite/nitrate level is inversely correlated with plasma low-density lipoprotein cholesterol level.
Topics: Case-Control Studies; Cholesterol, LDL; Coronary Disease; Female; Humans; Hypercholesterolemia; Male | 1997 |
Effect of diet induced hypercholesterolemia and selenium supplementation on nitric oxide synthase activity.
Topics: Animals; Antioxidants; Cholesterol; Cholesterol, Dietary; Citrulline; Enzyme Induction; Hypercholest | 1997 |
Pressor hyperreactivity to mental and hand-grip stresses in patients with hypercholesterolemia.
Topics: Baroreflex; Blood Platelets; Blood Pressure; Calcium; Cyclic GMP; Heart Rate; Humans; Hypercholester | 1999 |
A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA.
Topics: Acyl Coenzyme A; Animals; Aorta; Arteriosclerosis; Body Weight; Cholesterol, Dietary; Endothelium, V | 1999 |
Nitrite plasma levels in normolipemic and hypercholesterolemic arteriopathics after vasoactive and lipid-lowering treatment.
Topics: Aged; Arteries; Female; Fibrinolytic Agents; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lip | 1999 |
Nitrite plasma levels in normolipemic and hypercholesterolemic patients with peripheral occlusive arteriopathy.
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Hypercholesterolemia; Leg; Lipids; Male; Middle A | 1999 |
Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism.
Topics: Administration, Oral; Animals; Arginine; Body Weight; Cholesterol, Dietary; Collateral Circulation; | 2000 |
Paradoxical increase in nitric oxide synthase activity in hypercholesterolaemic rats with impaired renal function and decreased activity of nitric oxide.
Topics: Animals; Arginine; Cholesterol, Dietary; Cyclic GMP; Hypercholesterolemia; Kidney; Male; NADPH Dehyd | 2001 |
Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia?
Topics: Apolipoproteins B; Ascorbic Acid; Catalysis; Ceruloplasmin; Cholesterol; Cholesterol Esters; Cholest | 2001 |